Browsing Tag
Claret Capital Partners
1 post
Neurent Medical secures €25m growth debt to expand NEUROMARK commercialization
Neurent Medical has secured a €25 million growth-debt facility from Claret Capital after completing a €62.5 million Series C, giving the chronic rhinitis device company additional commercial firepower without immediately returning to shareholders for another equity round.